The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck.
- Kupferman, M.E.
- Kubik, M.W.
- Bradford, C.R.
- Civantos, F.J.
- Devaney, K.O.
- Medina, J.E.
- Rinaldo, A.
- Stoeckli, S.J.
- Takes, R.P.
- Ferlito, A.
Publication date
January 2014
DOI Publisher
Elsevier BV ISSN
0196-0709 Citation count (estimate)
6Abstract
Item does not contain fulltextFrom 18% to 35% of cutaneous melanomas are located in the head and neck, and nearly 70% are thin (Breslow thickness /=0.75mm, particularly when accompanied by adverse features including mitotic rate >/=1 per mm2, ulceration, and extensive regression. SLNB should also be strongly considered in younger patients (e.g. <40years old), especially in the presence of additional adverse features. All patients who do not proceed with sentinel lymph node biopsy must be carefully followed to monitor for regional relapse.1 maart 201
Add to ORKG